These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 8614980

  • 1. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
    Schoppel K, Hassfurther E, Britt W, Ohlin M, Borrebaeck CA, Mach M.
    Virology; 1996 Feb 01; 216(1):133-45. PubMed ID: 8614980
    [Abstract] [Full Text] [Related]

  • 2. Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.
    Speckner A, Glykofrydes D, Ohlin M, Mach M.
    J Gen Virol; 1999 Aug 01; 80 ( Pt 8)():2183-2191. PubMed ID: 10466818
    [Abstract] [Full Text] [Related]

  • 3. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD, Barrett AD.
    Virology; 2007 Sep 30; 366(2):349-60. PubMed ID: 17719070
    [Abstract] [Full Text] [Related]

  • 4. Identification of a variant A-specific neutralizing epitope on glycoprotein B (gB) of human herpesvirus-6 (HHV-6).
    Takeda K, Okuno T, Isegawa Y, Yamanishi K.
    Virology; 1996 Aug 01; 222(1):176-83. PubMed ID: 8813034
    [Abstract] [Full Text] [Related]

  • 5. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
    Navarro D, Lennette E, Tugizov S, Pereira L.
    J Med Virol; 1997 Aug 01; 52(4):451-9. PubMed ID: 9260696
    [Abstract] [Full Text] [Related]

  • 6. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
    Hiramatsu K, Tadano M, Men R, Lai CJ.
    Virology; 1996 Oct 15; 224(2):437-45. PubMed ID: 8874504
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT, Bolin RA, Kelly RG.
    Virology; 1998 Jul 05; 246(2):317-28. PubMed ID: 9657950
    [Abstract] [Full Text] [Related]

  • 9. Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.
    Britt WJ, Jarvis MA, Drummond DD, Mach M.
    J Virol; 2005 Apr 05; 79(7):4066-79. PubMed ID: 15767408
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antigenic domains analysis of classical swine fever virus E2 glycoprotein by mutagenesis and conformation-dependent monoclonal antibodies.
    Chang CY, Huang CC, Lin YJ, Deng MC, Chen HC, Tsai CH, Chang WM, Wang FI.
    Virus Res; 2010 May 05; 149(2):183-9. PubMed ID: 20132851
    [Abstract] [Full Text] [Related]

  • 12. [Conserved amino-acid residue mutations in epitope of human cytomegalovirus antigen M].
    Wang B, Liu Z, Liu Y, Shen B, Liu C, Shao N.
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul 05; 24(7):1128-32. PubMed ID: 18837384
    [Abstract] [Full Text] [Related]

  • 13. Syngeneic monoclonal anti-idiotype antibodies that bear the internal image of a human cytomegalovirus neutralization epitope.
    Keay S, Rasmussen L, Merigan TC.
    J Immunol; 1988 Feb 01; 140(3):944-8. PubMed ID: 2448380
    [Abstract] [Full Text] [Related]

  • 14. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
    Tugizov S, Navarro D, Paz P, Wang Y, Qadri I, Pereira L.
    Virology; 1994 Jun 01; 201(2):263-76. PubMed ID: 8184537
    [Abstract] [Full Text] [Related]

  • 15. Autoreactivity of primary human immunoglobulins ancestral to hypermutated human antibodies that neutralize HCMV.
    McLean GR, Cho CW, Schrader JW.
    Mol Immunol; 2006 May 01; 43(12):2012-22. PubMed ID: 16423397
    [Abstract] [Full Text] [Related]

  • 16. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM, Buratti E, Jones TD, North P, Baralle F, McLain L, McInerney T, Durrani Z, Dimmock NJ.
    Virology; 2000 Jan 05; 266(1):66-78. PubMed ID: 10612661
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.
    Li L, Barrett AD, Beasley DW.
    Virology; 2005 Apr 25; 335(1):99-105. PubMed ID: 15823609
    [Abstract] [Full Text] [Related]

  • 18. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides.
    Chassot S, Lambert V, Kay A, Godinot C, Roux B, Trepo C, Cova L.
    Virology; 1993 Jan 25; 192(1):217-23. PubMed ID: 7685963
    [Abstract] [Full Text] [Related]

  • 19. Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus.
    Lantto J, Fletcher JM, Ohlin M.
    Virology; 2003 Jan 05; 305(1):201-9. PubMed ID: 12504553
    [Abstract] [Full Text] [Related]

  • 20. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
    Zheng X, Schirmbeck R, Hilken G, Waters JA, Yang D, Reimann J, Roggendorf M, Lu M.
    Virology; 2002 Mar 15; 294(2):342-53. PubMed ID: 12009876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.